Fortress Biotech, 10% Owner of Avenue Therapeutics ATXI, has filed 1 purchase and 1 sale on the open market. The latest trade was on 01/02.

Fortress Biotech

10% Owner

Company

Avenue Therapeutics ATXI

First filing

23/01/04

Trades

33 trades

Buys / sales

1 / 1

12-month net buying

No record

Last trade

01/02

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
CT Checkpoint Therapeutics	Open-market sale	25/05/29	25/06/03	100,000 sh	$1.29	$129,000	−1.6%
Avenue TherapeuticsATXI	Open-market buy	23/09/08	23/09/12	418,410 sh	$0.72	$301,255.2	+68.1%